Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_15-cv-01795/USCOURTS-cand-3_15-cv-01795-1/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 15:78m(a) Securities Exchange Act

---

- 1 - 

SCHEDULING STIPULATION AND ORDER 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

FRANCIS J. BONANNO, individually 

and on behalf of all others similarly 

situated, 

 Plaintiff, 

 v. 

CELLULAR BIOMEDICINE GROUP, 

INC., et al., 

 Defendants. 

Case No.: 15-CV-01795-WHO 

SCHEDULING STIPULATION AND 

ORDER

WHEREAS, by Order dated November 3, 2015, this Court set the following 

schedule: Motions to be filed by January 19, 2016, Opposition Briefs by February 22, 

2016, Reply Briefs by March 23, 2016, and a hearing to be held on April 6, 2016 at 2 

p.m. 

WHEREAS, on January 19, 2016, three separate briefs from five defendants 

totaling fifty seven (57) pages, in support of Motions to Dismiss, were electronically 

filed. 

WHEREAS, the parties have convened and negotiated proposed alterations to 

the schedule, 

NOW THEREFORE, the parties stipulate and agree as follows: 

1. Plaintiffs will file their Opposition to the Motions to Dismiss on or before 

March 1, 2016. 

Case 3:15-cv-01795-WHO Document 63 Filed 02/08/16 Page 1 of 4
- 2 - 

SCHEDULING STIPULATION AND ORDER 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2. Plaintiffs may file a single omnibus brief in Response to all of the filed 

Motions, not to exceed sixty (60) pages in length. 

3. Any Defendant who filed a motion to dismiss may file a reply in further 

support of their motion on or before March 31, 2016. 

4. The April 6, 2016 hearing date will remain unchanged. 

Dated: February 3, 2016 KAUFHOLD GASKIN LLP 

/s/ Jonathan B. Gaskin 

Jonathan B. Gaskin 

388 Market Street, Ste. 1300 

San Francisco, CA 94920 

T: 415-445-4621 

F: 415-874-1071 

jgaskin@kaufholdgaskin.com 

 

ELLENOFF GROSSMAN & SCHOLE LLP 

Adrienne Marie Ward (pro hac vice) 

1345 Avenue of the Americas 

New York, NY 10105 

T: 212-370-1300 

award@egsllp.com 

Counsel for Defendants Cellular 

Biomedicine Group, Inc., and Wei Cao

JORGENSON, SIEGEL, McCLURE & 

FLEGEL, LLP

/s/ Gregory Klingsporn 

1100 Alma Street, Ste. 210 

Menlo Park, CA 94025 

T: 650-324-9300 

F: 650-324-0227 

gkk@jsmf.com

Case 3:15-cv-01795-WHO Document 63 Filed 02/08/16 Page 2 of 4
- 3 - 

SCHEDULING STIPULATION AND ORDER 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

SICHENZIA ROSS FRIEDMAN FERENCE 

LLP

Irwin Weltz (pro hac vice) 

61 Broadway, 32nd Floor 

New York, NY 10006 

T: 212-930-9700 

F: 212-930-9725 

iweltz@srff.com

Attorneys for Defendants LifeTech Capital, and 

Stephen M. Dunn

SHARTSIS FRIESE LLP

/s/ Jahan P. Raissi 

One Maritime Plaza, Eighteenth Floor 

San Francisco, CA 94111 

T: 415-421-6500 

F: 415-421-2922 

jraissi@sflaw.com

Attorneys for Defendant Streetwise Report LLC 

THE ROSEN LAW FIRM 

/s/ Laurence Rosen 

Laurence Rosen 

Jacob A. Goldberg (pro hac vice) 

275 Madison Avenue, 34th Floor 

New York, NY 10016 

T: 212-686-1060 

F: 212-226-4684 

lrosen@rosenlegal.com

jgoldberg@rosenlegal.com 

Lead Counsel for Lead Plaintiff Michelle 

Jackson and the Putative Class

 

Case 3:15-cv-01795-WHO Document 63 Filed 02/08/16 Page 3 of 4
- 4 - 

SCHEDULING STIPULATION AND ORDER 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

ORDER

Upon stipulation of the parties, as modified, and good cause appearing: 

IT IS SO ORDERED. 

Dated: February ___, 2016 

 ______________________________ 

 The Honorable William H. Orrick 

United States District Judge 

Case 3:15-cv-01795-WHO Document 63 Filed 02/08/16 Page 4 of 4